JW (Cayman) Therapeutics Co. Ltd（药明巨诺-B，股票代码02126）于2026年4月8日发布2026年3月股份变动月报表。报告显示，截至2026年3月31日，公司注册股本总额仍为5,000,000,000股，面值每股USD 0.00001，总额USD 50,000，较上月无变化。
报告期内，公司已发行普通股为416,473,250股，与上月底持平，未发生新增发行、购回或注销等活动，库藏股数量维持在0股。公司在期权与激励计划方面披露了多项股权激励授予方案，但本月并未产生任何期权行使或变动记录，相关股份数量与此前保持一致。
公司表示将继续遵守香港联交所《上市规则》以及相关法律法规。根据公告信息，本报告由执行董事田丰签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.